Ticker

ZBIO

Zenas BioPharma, Inc.

Quiet Money · how it holds up when sold

No Quiet Money read for ZBIO yet. Pro adds any actively traded US stock overnight. See Pro →

The other money · last 90 days

Nothing in the filings leans either way.

ZBIO in the last 90 days

Zenas BioPharma, Inc. (ZBIO) short interest: FINRA’s latest report (settlement 30 OCT 2026) shows 11,354,403 shares held short, 24.1 days to cover, down 9.4% from the report before.

What the filings show

How the other money is read

Filings read · last 90 days

1 of 4 inputs has filings

Balanced

Leaning outBalancedLeaning in

The disclosed money is split, on what has actually been filed. This reads on one input only, so treat it lightly.

Not in this read: insider purchases (none filed in 90 days); US House trades (none filed in 90 days); EU short registers (they cover European-listed companies). A missing input is left out, not counted as balanced.

Short interest
Short interest fell 3.0% — 11,702,288 to 11,354,403 shares between 31 AUG 2026 and 30 OCT 2026. See the filings →
Neutral

This summarises filings that have already been published — it is not a forecast, a rating of the company, or advice. Every figure above is listed in full further down this page, with the document it came from.

FINRA short interest

Settlement 30 OCT 2026 · shares held short

11,354,403shares held short

Days to cover

24.08

Avg daily volume

471,475

Since last report

-9.44%

What this number means ↓

As of 30 October 2026, 11,354,403 Zenas BioPharma, Inc. shares were held short — the total across every reporting firm, not one fund's position. That is 1,184,146 shares fewer than the previous report, a 9.44% decrease. At the average daily volume of 471,475 shares, that position represents 24.08 days of trading — what the filing calls days to cover.

This is the most recent figure that exists, and it is 24 days old. FINRA collects short interest twice a month, on a settlement date, and publishes it seven business days later. So nobody has a live short-interest number for ZBIO — not us, and not anyone quoting one. We print the settlement date on the figure so you always know which day you are looking at.

Across the 12 reports we hold, the position has risen from 10,687,286 shares on 15 May 2026 to 11,354,403 today, a change of 6.2%. The highest reading in that window was 12,538,549 shares on 15 October 2026.

SettlementShares shortDays to cover
30 OCT 202611,354,40324.08
15 OCT 202612,538,54918.83
30 SEPT 202611,941,60115.48
15 SEPT 202611,871,34622.43
31 AUG 202611,702,28814.18
14 AUG 202611,658,98621.06
31 JUL 202611,753,56613.83
15 JUL 202612,169,90712.46
30 JUN 202612,196,4369.64
15 JUN 202611,131,73919.33
29 MAY 202610,879,47018.13
15 MAY 202610,687,28621.31
Questions about short interest ↓
What is ZBIO's short interest?
11,354,403 shares, as of the 30 October 2026 settlement date. That is the figure FINRA published, unadjusted.
What percentage of the float is short?
We do not publish that, because FINRA does not publish float. The regulator reports the number of shares held short; turning it into a percentage needs a share count from somewhere else, and different sources disagree about what counts as float. We would rather give you the number that was actually filed than a percentage built on an assumption.
How current is this?
It is 24 days old, and that is as fresh as short interest gets. FINRA measures it twice a month and publishes it seven business days after the settlement date. Any site showing you a "live" short interest figure is showing you something else.
What does days to cover mean?
It is the short position divided by average daily trading volume — here, 24.08. It describes how many days of ordinary trading the position is equivalent to. It is arithmetic from the filing, not a prediction about what will happen.
Where does this come from?
FINRA's consolidated short interest file, which is public. We read it directly and store it unchanged, except that we blank the days-to-cover placeholder FINRA writes when a stock has almost no volume.
What this page will never showNo buy or sell ratingsNo price targetsNo forecastsIndicators are rules-based summaries of the filingsDocuments, dates, and how long they took to become public.